Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Choosing the best Dividend Aristocrats Etf for retirees involves yield, cost, and risk assessment. This intro guides the evaluation process.
22,751 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
The EMB ETF offers a ~6% yield on USD EM debt, but a hidden sovereign default risk can erode income and NAV during ma...
Whales are stepping in to buy the dip as Dogecoin dips to a 14-month low. On-chain data shows a notable uptick in lar...
Stocks and exchange-traded funds tied to PayPal surged after Reuters reported Stripe and Advent International were we...
Global equities outside the US have surged as growth improves and the dollar weakens. This article highlights three E...
Grok AI signals a measured Bitcoin advance through June 2026, forecasting a target around the mid-80Ks. The model cit...
Bitcoin edges toward a potential bottom as on-chain demand remains weak, signaling a fragile path to a durable recovery.
Google Gemini AI signals a potential XRP breakout within 60 days if the price closes above 1.18, with a risk of a sha...
Investors brace for a potential 2026 stock market crash as volatility rises. Three defensive ETFs offer ballast with ...
Fintech down this year has pressured growth equities, yet cybersecurity ETFs are delivering relative steadiness as co...
Meta AI projects a Bitcoin breakout by summer 2026, with targets near or above $100K. The call hinges on technical se...
A retail investor endured an 80% drawdown in a 3X semiconductor ETF, then capitalized on an AI-fueled rebound to turn...